Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jul 12, 2016
Insider Transaction Report
Form 4
Tubridy Karen L
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-07-09+13,328→ 26,672 totalExercise: $0.28From: 2016-07-09Exp: 2026-02-24→ Common Stock (13,328 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 40,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 13,328 shares.The option had previously vested with respect to 13,344 shares.